keyword
MENU ▼
Read by QxMD icon Read
search

neutrophil-to-lymphocyte ratio And Pancreatic Cancer

keyword
https://www.readbyqxmd.com/read/30505600/the-accuracy-of-neutrophil-to-lymphocyte-ratio-and-platelet-to-lymphocyte-ratio-as-a-marker-for-gastrointestinal-malignancies
#1
Ian Nora, Ravi Shridhar, Jamie Huston, Kenneth Meredith
Background: Accurate predictors of locally advanced and recurrence disease in patients with gastrointestinal cancer are currently lacking. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have emerged as possible markers for predicting recurrence in these patients. In this study, we sought to evaluate the utility of NLR and PLR in predicting the presence of regional nodal disease, metastasis and systemic recurrence in patients with gastrointestinal malignancies...
October 2018: Journal of Gastrointestinal Oncology
https://www.readbyqxmd.com/read/30396977/c-reactive-protein-based-prognostic-measures-are-superior-at-predicting-survival-compared-with-peripheral-blood-cell-count-based-ones-in-patients-after-curative-resection-for-pancreatic-cancer
#2
COMPARATIVE STUDY
Yuki Fujiwara, Koichiro Haruki, Hiroaki Shiba, Ryoga Hamura, Takashi Horiuchi, Yoshihiro Shirai, Kenei Furukawa, Takeshi Gocho, Katsuhiko Yanaga
AIM: Prognostic factors of recurrence and survival in various cancer types have been reported and include C-reactive protein (CRP)-based measures as evidenced by the Glasgow prognostic score (GPS), as well as peripheral blood cell-based prognostic values such as the prognostic index (PI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR). The aim of this study was to identify significant prognostic values and compare them for suitability for use in patients after curative pancreatic resection for pancreatic cancer...
November 2018: Anticancer Research
https://www.readbyqxmd.com/read/30360017/inflammatory-markers-as-prognostic-indicators-in-pancreatic-cancer-patients-who-underwent-gemcitabine-based-palliative-chemotherapy
#3
Hong Jun Kim, Suk-Young Lee, Dae Sik Kim, Eun Joo Kang, Jung Sun Kim, Yoon Ji Choi, Sang Cheul Oh, Jae Hong Seo, Jun Suk Kim
Background/Aims: Patients with pancreatic cancer (PC) generally have poor clinical outcomes. Early determination of their prognosis is crucial for developing a therapeutic strategy. Recently, various inflammatory markers have been validated as prognostic indicators for many cancers, including PC. However, few studies have evaluated these markers together. Thus, the purpose of this study was to comprehensively evaluate the value of inflammatory markers as prognostic indicators in patients with advanced PC treated with gemcitabine-based chemotherapy as the first line regimen...
October 26, 2018: Korean Journal of Internal Medicine
https://www.readbyqxmd.com/read/30233792/neutrophil-to-lymphocyte-ratio-as-a-predictor-of-postoperative-morbidity-in-patients-with-distal-cholangiocarcinoma
#4
Yusuke Kumamoto, Takashi Kaizu, Hiroshi Tajima, Nobuyuki Nishizawa, Shigenori Ei, Kazuharu Igarashi, Masahiko Watanabe
Systemic inflammatory-, immunological- and nutritional-based indices, such as the neutrophil-to-lymphocyte ratio (NLR), the prognostic nutritional index (PNI) and the Glasgow prognostic score (GPS), are drawing considerable research attention to predict the long-term prognosis of many types of cancer. Recently, these parameters have also been reported to be useful in predicting postoperative morbidity in several fields, including colorectal and otolaryngological cancer. However, while distal cholangiocarcinoma exhibits a high morbidity rate, its risk factors of morbidity have not yet been established...
October 2018: Molecular and Clinical Oncology
https://www.readbyqxmd.com/read/30230959/long-term-survival-of-pancreatic-cancer-patients-treated-with-multimodal-therapy-combined-with-wt1-targeted-dendritic-cell-vaccines
#5
Shuichi Hanada, Tomoko Tsuruta, Kouichi Haraguchi, Masato Okamoto, Haruo Sugiyama, Shigeo Koido
BACKGROUND/AIM: Pancreatic ductal adenocarcinoma (PDA) remains one of the most aggressive tumors with a dismally poor prognosis. Although surgical resection remains the only potentially curative treatment, most PDAs are not surgically resectable at diagnosis. Therefore, multimodal therapy is urgently needed to improve the long-term survival of PDA patients. METHODS: Six eligible PDA patients underwent multimodal therapy comprising dendritic cells (DCs) pulsed with Wilms' tumor 1 (WT1) peptide (DC/WT1-I) restricted by the human leukocyte antigen (HLA) class I (A*24:02 or A*02:06) allele, chemotherapy, radiation, and/or surgery...
September 19, 2018: Human Vaccines & Immunotherapeutics
https://www.readbyqxmd.com/read/30215041/identifying-the-role-of-neutrophil-to-lymphocyte-ratio-and-platelets-to-lymphocyte-ratio-as-prognostic-markers-in-patients-undergoing-resection-of-pancreatic-ductal-adenocarcinoma
#6
Alexandros Giakoustidis, Kyriakos Neofytou, Mafalda Costa Neves, Dimitrios Giakoustidis, Eleni Louri, David Cunningham, Satvinder Mudan
Backgrounds/Aims: It is important to point out that the identification of inflammation is an essential component of the pathogenesis and the progression of cancer. In this study, we analysed the neutrophil-to-lymphocyte ratio (NLR) and the platelets-to-lymphocyte ratio (PLR), with an overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC), who were treated with a resection following or not following a procedure of neoadjuvant chemotherapy/chemoradiation. We intended to identify the significance of the role of NLR and PLR, as prognostic markers in patients undergoing surgery for PDAC...
August 2018: Annals of Hepato-Biliary-Pancreatic Surgery
https://www.readbyqxmd.com/read/30196571/narca-a-novel-prognostic-scoring-system-using-neutrophil-albumin-ratio-and-ca19-9-to-predict-overall-survival-in-palliative-pancreatic-cancer
#7
Samuel J Tingle, George R Severs, Michael Goodfellow, John A Moir, Steven A White
BACKGROUND AND OBJECTIVES: Several serum based-markers and ratios have been investigated for their prognostic value in pancreatic ductal adenocarcinoma (PDAC). This cohort study aimed to combine these into a novel prognostic scoring system. METHODS: A retrospective cohort study was performed on 145 patients with unresectable histologically-confirmed PDAC. Based on the existing literature the following markers were investigated: neutrophil-lymphocyte ratio (NLR), neutrophil-albumin ratio (NAR), platelet-lymphocyte ratio (PLR), fibrinogen, and Ca19-9...
September 2018: Journal of Surgical Oncology
https://www.readbyqxmd.com/read/30194208/the-combination-of-neutrophil-to-lymphocyte-ratio-and-serum-carbohydrate-antigen-19-9-level-as-a-prognostic-indicator-in-patients-with-recurrent-pancreatic-cancer
#8
Teruhisa Sakamoto, Hiroaki Saito, E I Uchinaka, Masaki Morimoto, Masataka Amisaki, Naruo Tokuyasu, Soichiro Honjo, Keigo Ashida, Yoshiyuki Fujiwara
BACKGROUND/AIM: We retrospectively investigated the relationship between prognosis and combined neutrophil-to-lymphocyte ratio (NLR) and serum carbohydrate antigen 19-9 (CA19-9) levels in patients with recurrent pancreatic cancer. PATIENTS AND METHODS: We enrolled 66 patients whose pancreatic cancer recurred. RESULTS: Based on ROC analysis results, the patients were divided into NLRHigh (NLR ≥1.69) or NLRLow (NLR <1.69), and into CA19-9High (CA19-9 ≥107...
September 2018: Anticancer Research
https://www.readbyqxmd.com/read/30172265/-prognostic-value-of-neutrophil-to-lymphocyte-ratio-in-patients-with-lung-adenocarcinoma-treated-with-radical-dissection
#9
Gaoxiang Wang, Ran Xiong, Hanran Wu, Guangwen Xu, Caiwei Li, Xiaohui Sun, Mingran Xie
BACKGROUND: Previous studies have shown that the neutrophil-to-lymphocyte ratio (NLR) has a significant impact on the prognosis of many malignant tumors such as gastric cancer, colorectal cancer and pancreatic cancer, but the study on the prognosis of patients with resectable lung adenocarcinoma is less. The aim of this study is to investigate the correlation between the NLR and the clinicopathologic features of adenocarcinoma of lung patients who underwent radical pneumonectomy. Furthermore, this study aimed to clarify the predictive and prognostic significance of NLR in patients who underwent pneumonectomy for lung adenocarcinoma...
August 20, 2018: Zhongguo Fei Ai za Zhi, Chinese Journal of Lung Cancer
https://www.readbyqxmd.com/read/30167864/anergic-natural-killer-cells-educated-by-tumor-cells-are-associated-with-a-poor-prognosis-in-patients-with-advanced-pancreatic-ductal-adenocarcinoma
#10
Chao Yang, He Cheng, Yiyin Zhang, Kun Fan, Guopei Luo, Zhiyao Fan, Qiuyi Huang, Yu Lu, Kaizhou Jin, Zhengshi Wang, Xianjun Yu, Chen Liu
INTRODUCTION: Natural killer cells (NK) are often believed to play a positive role in the antitumor immune response. However, this is not the case for patients with advanced pancreatic cancer. This study was performed to determine the unique subtype of "educated" NK cells and their prognostic value in patients with advanced pancreatic cancer. METHODS: We divided 378 eligible patients into a derivation cohort (September 2010 to December 2014, n = 239) and a validation cohort (January 2015 to April 2016, n = 139)...
August 22, 2018: Cancer Immunology, Immunotherapy: CII
https://www.readbyqxmd.com/read/30151266/retrospective-comparison-of-the-efficacy-and-the-toxicity-of-standard-and-modified-folfirinox-regimens-in-patients-with-metastatic-pancreatic-adenocarcinoma
#11
Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, Audrey Cabral, Thiago Pimentel Muniz, Luciana de Moura Leite, Lucas Ferreira Sant'Ana
Background: FOLFIRINOX stands a major breakthrough in the management of metastatic pancreatic adenocarcinoma (MPA). Nonetheless, significant side-effects have been reported using standard FOLFIRINOX. We aimed to compare survival outcomes, response rates and toxicity of patients treated with standard or modified FOLFIRINOX in MPA. Methods: We included patients aged ≥18 years old, with pathologically confirmed MPA, treated with FOLFIRINOX in the first-line setting...
August 2018: Journal of Gastrointestinal Oncology
https://www.readbyqxmd.com/read/30097739/clinical-impact-of-neoadjuvant-therapy-on-nutritional-status-in-pancreatic-cancer
#12
Mitsuru Tashiro, Suguru Yamada, Fuminori Sonohara, Hideki Takami, Masaya Suenaga, Masamichi Hayashi, Yukiko Niwa, Chie Tanaka, Daisuke Kobayashi, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Tsutomu Fujii, Yasuhiro Kodera
BACKGROUND: The association between neoadjuvant therapy (NAT) and nutritional status in pancreatic cancer (PC) is unknown. OBJECTIVE: The aim of this study was to assess the impact of NAT on nutritional status. METHODS: Overall, 161 patients who underwent pancreatoduodenectomy for PC between August 2010 and March 2017 were enrolled and were divided into two groups: the neoadjuvant group (NAG; n = 67) and the control group (CG; n = 94)...
October 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/30014292/the-prognostic-value-of-preoperative-neutrophil-to-lymphocyte-ratio-in-resected-patients-with-pancreatic-adenocarcinoma
#13
Le-Ping Fang, Xiao-Yan Xu, Yu Ji, Pu-Wen Huang
PURPOSE: This research aims to analyze neutrophil-to-lymphocyte ratio (NLR) for resectable pancreatic ductal adenocarcinoma (PDAC) patients and reveal its predictive value. METHODS: We enrolled 389 pancreatic adenocarcinoma patients who had undergone curative surgery between January 1, 2008 and August 15, 2015 in Jiangsu Provincial People's Hospital, and they were followed up until December 20, 2016. Among them, 219 patients had definite recurrence record in our hospital...
November 2018: World Journal of Surgery
https://www.readbyqxmd.com/read/29983708/neutrophil-to-lymphocyte-ratio-as-a-predictor-of-poor-prognosis-in-metastatic-pancreatic-cancer-patients-treated-with-nab-paclitaxel-plus-gemcitabine-a-propensity-score-analysis
#14
J Ventriglia, A Petrillo, M Huerta Alváro, M M Laterza, B Savastano, V Gambardella, G Tirino, L Pompella, A Diana, F Iovino, T Troiani, E Martinelli, F Morgillo, M Orditura, A Cervantes, F Ciardiello, F De Vita
Background: High neutrophil to lymphocyte ratio (NLR) has shown to be a predictor of poor outcomes in various malignancies, including pancreatic cancer. Methods: We assessed 70 consecutive pts with histologically confirmed mPC who received chemotherapy with nab-paclitaxel/gemcitabine at two different European oncologic centers between January 2012 and November 2015. Variables assessed for prognostic correlations included age ≥ 66, sex, Karnofsky PS score, primary tumor site, baseline CA19...
2018: Gastroenterology Research and Practice
https://www.readbyqxmd.com/read/29977290/prognostic-roles-of-inflammatory-markers-in-pancreatic-cancer-comparison-between-the-neutrophil-to-lymphocyte-ratio-and-platelet-to-lymphocyte-ratio
#15
Dongwook Oh, Jung-Soo Pyo, Byoung Kwan Son
Background/Objectives: This meta-analysis is aimed at investigating the prognostic roles of the inflammatory markers neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with pancreatic cancer. Methods: The correlations between high inflammatory marker expression levels and prognosis in 7105 patients with pancreatic cancer from 34 eligible studies were investigated. Additionally, subgroup analyses based on study location, tumor stage, treatment, and value cutoffs were performed...
2018: Gastroenterology Research and Practice
https://www.readbyqxmd.com/read/29923983/increased-platelet-to-lymphocytes-ratio-is-associated-with-poor-long-term-prognosis-in-patients-with-pancreatic-cancer-after-surgery
#16
Jinming Yu, Zhaoyan Ding, Yuanming Yang, Shanli Liu
Several studies reported platelet-to-lymphocytes ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) were associated with the mid-term survival or cancer stage in pancreatic cancer. However, the relationship between these markers and the long-term prognosis of pancreatic cancer is still unknown. We investigated the relationship between PLR, NLR, RDW, and the long-term prognosis of pancreatic cancer.We included 182 pancreatic cancer patients who received operation at Linzi District People 's Hospital between August 2010 and January 2017...
June 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29910636/performance-status-dynamics-during-treatment-with-nab-paclitaxel-plus-gemcitabine-versus-gemcitabine-alone-for-metastatic-pancreatic-cancer
#17
E Gabriela Chiorean, Daniel Von Hoff, Yin Wan, Sandra Margunato-Debay, Marc Botteman, David Goldstein
Objectives: This analysis examined changes in Karnofsky performance status (KPS) as a surrogate for patient's well-being during treatment with nab -paclitaxel plus gemcitabine vs gemcitabine alone as first-line therapy for metastatic pancreatic cancer (MPC) in the Phase III MPACT trial. Participants and methods: Descriptive analyses were performed for KPS at three time points (3 and 6 months after randomization and 1 month before disease progression) and for time to any KPS deterioration...
2018: Cancer Management and Research
https://www.readbyqxmd.com/read/29807728/preoperative-neutrophil-to-lymphocyte-ratio-as-a-prognosticator-in-early-stage-pancreatic-ductal-adenocarcinoma
#18
Tomoyuki Abe, Hironobu Amano, Tsuyoshi Kobayashi, Keiji Hanada, Masahiro Nakahara, Hideki Ohdan, Toshio Noriyuki
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR), which reflects the cancer-induced systemic inflammation response, has been proposed as a risk factor for poor long-term prognosis in cancer. We investigated the prognostic role of the NLR and the relationship between the NLR and TNM stage in pancreatic ductal adenocarcinoma (PDAC) patients following curative resection. METHODS: One-hundred thirty-eight consecutive patients with resected PDAC were enrolled between 2004 and 2014...
October 2018: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/29691738/a-novel-physiobiological-parameter-based-grading-system-for-resectable-pancreatic-cancer
#19
Takehiro Okabayashi, Yasuo Shima, Tatsuaki Sumiyoshi, Kenta Sui, Jun Iwata, Sojiro Morita, Yasuhiro Shimada, Tatsuo Iiyama
BACKGROUND: Preoperative methods to estimate disease-specific survival (DSS) for resectable pancreatic cancer are limited. OBJECTIVE: The aim of this study was to develop and validate a pretreatment physiobiological prognostic model in patients with radiologically resectable pancreatic cancer. METHODS: A retrospective review of a prospectively maintained institutional database was undertaken to identify patients who underwent potentially curative resection for radiologically resectable pancreatic cancer...
July 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29670365/prognostic-value-of-platelet-to-lymphocyte-ratio-in-pancreatic-cancer-a-comprehensive-meta-analysis-of-17-cohort-studies
#20
REVIEW
Yongping Zhou, Sijin Cheng, Abdel Hamid Fathy, Haixin Qian, Yongzhao Zhao
Background and aims: Several studies were conducted to explore the prognostic value of platelet-to-lymphocyte ratio (PLR) in pancreatic cancer and have reported contradictory results. This study aims to summarize the prognostic role of PLR in pancreatic cancer. Materials and methods: Embase, PubMed and Cochrane Library were completely searched. The cohort studies focusing on the prognostic role of PLR in pancreatic cancer were eligible. The overall survival (OS) and progression-free survival (PFS) were analyzed...
2018: OncoTargets and Therapy
keyword
keyword
162937
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"